Co-infusion of GLP-1 and GCG has been shown to reduce glucagon-induced hyperglycemia, lower blood glucose levels, suppress food intake, and enhance energy expenditure in both diabetic obese mice and healthy human volunteers [78]
While in this model, choline deprivation altered lipid composition in the liver, decreasing sphingomyelin and specific glycerophospholipids with 34:1 fatty acids, leading to reduced inflammation, its impact on brain lipid metabolism was less pronounced (101)
The difference between the two therapeutic approaches is the continuous chronic secretion of leptin mediated by gene delivery versus the intermittent bolus delivery and rapid clearance of daily injection of rh-leptin protein (Morsy et al., 1998)
This targeted approach prioritizes the direct impact of semaglutide on weight reduction
This progressive improvement was confirmed by repeated measures ANOVA